Offer - Urjas Oil for just ₹ 1
Erlokem 100 Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer.
The right dosage of Erlokem 100 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Erlokem 100 Tablet can also lead to other problems, which have been listed below. These side effects of Erlokem 100 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Erlokem 100 Tablet is Moderate for pregnant women and Moderate for women who are breastfeeding. Warnings related to Erlokem 100 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Liver Disease, Kidney Disease, Lung Disease must refrain from the use of Erlokem 100 Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Erlokem 100 Tablet are listed in the contraindications section below.
Besides this, Erlokem 100 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Erlokem 100 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Erlokem 100 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Erlokem 100 Tablet safe for pregnant women?
Erlokem may have some side effects during pregnancy. Pregnant women should discontinue the use of Erlokem, and talk to their doctor, if they notice any discomfort.
Is the use of Erlokem 100 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Erlokem. If you see any side effects, stop taking Erlokem immediately and talk to your doctor. Take Erlokem again, only after your doctor's advice.
What is the effect of Erlokem 100 Tablet on the Kidneys?
Erlokem is completely safe for kidneys.
What is the effect of Erlokem 100 Tablet on the Liver?
Erlokem can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Erlokem 100 Tablet on the Heart?
You can take Erlokem without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Erlokem 100 Tablet unless your doctor advises you to do so -
Is this Erlokem 100 Tablet habit forming or addictive?
Forming a habit of Erlokem 100 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Erlokem 100 Tablet, you should not drive or work on any heavy machine, as Erlokem 100 Tablet can make you drowsy.
Is it safe?
Erlokem 100 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Erlokem 100 Tablet is not used to treat mental disorders.
Interaction between Food and Erlokem 100 Tablet
Some foods when eaten with Erlokem 100 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Erlokem 100 Tablet
Information about the interaction of Erlokem 100 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tarceva® (erlotinib)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 514-516
